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The growth physiology of Escherichia coli during colonization of the intestinal tract was studied with four
animal models: the streptomycin-treated mouse carrying a reduced microflora, the monoassociated mouse with
no other microflora than the introduced strain, the conventionalized streptomycin-treated mouse, and the
conventionalized monoassociated mouse harboring a full microflora. A 23S rRNA fluorescent oligonucleotide
probe was used for hybridization to whole E. coli cells fixed directly after being taken from the animals, and
the respective growth rates of E. coli BJ4 in the four animal models were estimated by correlating the cellular
concentrations of ribosomes with the growth rate of the strain. The growth rates thus estimated from the
ribosomal content of E. coli BJ4 in vivo did not differ in the streptomycin-treated and the monoassociated mice.
After conventionalization there was a slight decrease of the bacterial growth rates in both animal models.
only 0.1 to 1% of the flora, are removed (10). This is sufficient
to remove the colonization barrier for incoming enteric bacteria, such as Escherichia coli, which will grow quickly to a level
of 107 to 108 CFU/g of feces; this level is 10- to 50-fold lower
than levels found in monoassociated animals but still 104-fold
higher than those found in conventional animals (10, 19). Conventionalized mice received oral inoculation of a homogenate
containing cecal contents from a conventional mouse.
In the present investigation (as in previous investigations
[13, 18, 19]), we have monitored colonization and excretion of
E. coli BJ4 in mouse intestines. E. coli BJ4 was originally
isolated from a healthy Wistar rat at the Institute of Toxicology, National Food Agency, Copenhagen, Denmark. A streptomycin-resistant isolate which was found to be identical to its
parental strain with respect to biochemical reactions and serology was used (12). The influence of the normal microflora
on this bacterial species in a conventional gastrointestinal environment was investigated by addition of a complete mouse
intestinal flora to monoassociated and inoculated, streptomycin-treated mice.
The strong correlation between cell growth rate and rRNA
content (2, 11, 21) makes it possible to use quantitative in situ
hybridization with fluorescent rRNA probes to estimate
growth rates of single cells (16, 18, 19). For this estimation, an
in vitro standard curve, based on suspended cultures of the
organism under investigation growing at different rates in different media, is required. The cellular fluorescence of bacteria
in samples from the respective animals was compared to that
described by the standard curve, and generation times were
estimated. Detailed protocols for such determinations have
been presented previously (13, 17–19).
Eleven each of germfree and streptomycin-treated, albino,
adult male mice of the NMRI/KI strain were used in the study.
The mouse strain originates from the Institute fur Versuchsti-

Bacterial colonization of the mammalian gut plays two important roles. On one hand, it provides protection against
pathogens and carries out digestive processes. On the other
hand, it is a prerequisite of virulence for many pathogenic
bacteria. The intestinal tract represents a complex ecosystem,
harboring 400 to 500 different bacterial species. Densities of up
to 1012 bacteria per g of contents have been reported (1, 5).
This indigenous flora constitutes a highly competitive environment and a colonization barrier (3, 6, 8, 20, 24), which decreases the probability that ingested bacteria will be able to
establish themselves in the intestinal ecosystem of a healthy
host. It is important to understand how bacteria colonize the
gut, how they find their optimal niche, and how they may be
excreted as a consequence of the appearance of a new organism having more effective colonization factors, such as specific
adhesion capacity, better utilization of nutrients, or faster
growth (9).
In order to examine the influence of the microflora on the
growth of a single species, four different animal models were
investigated: germfree mice, streptomycin-treated mice, conventionalized germfree mice, and conventionalized streptomycin-treated mice. Germfree mice have no intestinal microflora
and are excellent models for studies of single bacteria since
there is no competition from other bacterial species, which
makes it very easy for an incoming bacterium to establish itself,
proliferate, and persist in the gastrointestinal tract at a high
density. A streptomycin-treated mouse is a conventional
mouse which is treated with streptomycin, after which most
facultative aerobic, gram-negative rods, normally constituting
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Microbial Ecology, Karolinska Institute, Stockholm,4 Sweden; Department for Microbiology, The Technical
University of Denmark, Lyngby,2 and Department of Gastrointestinal Infections, Statens Seruminstitut,
Copenhagen,3 Denmark; School of Microbiology and Immunology, University of New South Wales,
Kensington, Australia5; Department of Zoology, University of Maryland, College Park, Maryland6;
and Department of Biochemistry, Microbiology, and Molecular Genetics, University of
Rhode Island, Kingston, Rhode Island7

VOL. 6, 1999

erzucht, Hanover, Germany, and has been inbred for 37 generations at the Department of Medical Microbial Ecology,
Karolinska Institute, Stockholm, Sweden. The germfree mice
were kept under standard conditions (22 6 2°C; 50% 6 10%
relative humidity; light-dark cycle, 12 h-24 h) as described
previously (4). Eleven conventional mice were given drinking
water containing 5 g of streptomycin sulfate per liter (starting
24 h before the colonization experiment), until the time of
conventionalization (6 days after inoculation). Thereafter, they
received tap water with no streptomycin added.
The germfree mice were orally dosed with a 0.1-ml aliquot of
a stationary-phase E. coli BJ4 suspension containing 5 3 106
CFU/ml. The streptomycin-treated mice were given 0.1 ml
containing 100-fold more cells to ensure colonization. Before
oral dosing, aliquots of homogenized fecal samples (negative
controls) were fixed for hybridization (13, 18, 19). Six days after
inoculation, the mice (germfree and streptomycin treated)
were conventionalized per os with 100 ml of a homogenate of
cecal contents isolated from a conventional mouse, diluted
10-fold in 0.9% NaCl. The homogenate contained 1.3 3 106 E.
coli cells/ml. No streptomycin-resistant colonies were detected
in the homogenate. Two mice of each animal model were
sacrificed at 1, 3, and 5 h and on days 7 and 10. On day 15, one
mouse of each model was sacrificed. From each of the sacrificed mice, samples of feces (excluding the 1-, 3-, and 5-h
samplings, since the bacteria reach the cecum faster than they
do the feces), cecal contents, and cecal mucus were taken for
CFU determination and fixation. The cecal samplings were
carried out as described previously (13, 19).
When the ribosomal probe EC 1531, which is specific for E.
coli 23S rRNA (18, 19), was used for quantification of the
fluorescence in E. coli BJ4 in fecal samples from the streptomycin-treated and the monoassociated mice, it was estimated
that the generation time was constant from days 1 to 6 in both
animal models, varying between 70 and 89 min (Fig. 1). This
relatively fast growth of E. coli BJ4 in the two animal models is
consistent with previous findings for streptomycin-treated mice
(19). After inoculation with a normal cecal flora on day 6, the
estimated generation times of the E. coli cells increased to 130
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FIG. 2. Observed concentration of E. coli BJ4 cells before and after conventionalization of streptomycin-treated (closed circles) and monoassociated (open
circles) mice. Mice were conventionalized on day 6 by oral inoculation of a
homogenate containing cecal contents from a conventional mouse.

min for the streptomycin-treated and 116 min for the monoassociated mice on day 15. Statistical analysis revealed that the
increasing trend was significant, although weak. The similarity
of the estimated growth rates of E. coli BJ4 in monoassociated
mice and streptomycin-treated mice indicates that the large
number of bacteria in the streptomycin-treated mice had no
influence on the growth of the E. coli BJ4 strain.
The population sizes of E. coli BJ4 had reached steady states
of 1.2 3 1010 CFU/g of feces in the monoassociated mice and
7.1 3 108 CFU/g in the streptomycin-treated mice by day 6
(Fig. 2). At day 6 after inoculation, the mice were conventionalized with a normal cecal flora, leading to a fast reduction of
E. coli BJ4 levels in both animal models. The decrease in BJ4
levels in the monoassociated mice was particularly high; the
number of CFU per gram was reduced from 1.2 3 1010 to a
new stable level of 2.1 3 105 in 8 days (Fig. 2), a drop of 4
orders of magnitude, consistent with the studies by Freter et al.
(9). However, in the same time period, in conventionalized
streptomycin-treated mice (Fig. 2) the BJ4 level dropped less
than 100-fold to a level of 107 CFU/g.
The prevalent theory as to how bacteria colonize the mammalian gut is that all species can coexist as long as each member of the flora is able to utilize one or a few limiting nutrients
better than all the others and that the rate of bacterial growth
during the colonization process is greater than the washout
rate from the intestine (8, 9). It is also possible for a species
which does not compete well for limiting nutrients to avoid
washout and to colonize if it is able to adhere to the intestinal
wall (8, 9).
In the streptomycin-treated mouse, E. coli BJ4 should occupy its normal narrow nutrient niche (22, 23) and, once established, be able to compete well with incoming enterics. In
the germfree mouse, however, E. coli BJ4 should be free to
utilize any nutrient, including many for which it would compete
very poorly against normal intestinal residents. Moreover, the
flora in the streptomycin-treated mouse should make it more
difficult for incoming bacteria to grow and colonize, whereas in
the germfree mouse no such barrier exists. Therefore, if the
colonization theory is correct, it would be expected that E. coli
BJ4 in the streptomycin-treated mouse model would be more
resistant to administration of the cecal flora of a conventional
mouse than BJ4 would be in the germfree mouse model. This
is, in fact, observed in the present experiments (Fig. 2). Since
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FIG. 1. Estimated generation times (means 6 standard errors of the means)
of E. coli BJ4 in feces from streptomycin-treated (closed circles) and the monoassociated (open circles) mice, as determined by hybridization of fixed fecal
samples. Animals were orally inoculated with E. coli BJ4 on day 0. On day 6, they
were conventionalized by oral inoculation of a homogenate containing cecal
contents from a conventional mouse.

NOTES

436

NOTES

CLIN. DIAGN. LAB. IMMUNOL.

We thank Anna-Carin Persson and Johannes Bergstedt, Karolinska
Institute, for excellent assistance with the animals.
We acknowledge the financial support provided by NorFa (Nordic
Academy for Advanced Study), Oslo, Norway.
REFERENCES
1. Borriello, S. P. 1986. Microbial flora of the gastrointestinal tract, p. 2–16. In
M. J. Hill (ed.), Microbial metabolism in the digestive tract. CRC Press, Inc.,
Boca Raton, Fla.

2. Bremer, H., and P. P. Dennis. 1996. Modulation of chemical composition
and other parameters of the cell by growth rate, p. 1553–1569. In F. C.
Neidhardt, R. Curtiss III, J. L. Ingraham, E. C. C. Lin, K. B. Low, B.
Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger
(ed.), Escherichia coli and Salmonella: cellular and molecular biology, 2nd
ed., vol. 2. ASM Press, Washington, D.C.
3. Dubos, R., R. W. Schadler, and R. Costello. 1963. Composition, alterations,
and effects of the intestinal flora. Fed. Proc. 22:1322–1329.
4. El-Bayoumy, K., S. S. Hecht, and D. Hoffmann. 1982. Comparative tumor
initiating activity on mouse skin of 6-nitrobenzol[a]pyrene, 6-nitrochrysene,
3-nitroperylene, 1-nitropyrene and their parent hydrocarbons. Cancer Lett.
16:333–337.
5. Finegold, S. M., V. L. Sutter, and G. E. Mathisen. 1983. Normal indigenous
intestinal flora, p. 3–31. In D. J. Hentges (ed.), Human intestinal microflora
in health and disease. Academic Press, New York, N.Y.
6. Freter, R. 1956. Experimental enteric Shigella and Vibrio infections in mice
and guinea pigs. J. Exp. Med. 104:411–418.
7. Freter, R. 1978. Possible effects of foreign DNA on pathogenic potential and
intestinal proliferation of Escherichia coli. J. Infect. Dis. 137:624–629.
8. Freter, R. 1983. Mechanisms that control the microflora in the large intestine, p. 33–54. In D. J. Hentges (ed.), Human intestinal microflora in health
and disease. Academic Press, New York, N.Y.
9. Freter, R., H. Brickner, J. Fekete, M. M. Vickerman, and K. E. Carey. 1983.
Survival and implantation of Escherichia coli in the intestinal tract. Infect.
Immun. 39:686–703.
10. Hentges, D. J. 1983. Role of the intestinal microflora in host defense against
infection, p. 311–331. In D. J. Hentges (ed.), Human intestinal microflora in
health and disease. Academic Press, New York, N.Y.
11. Kjeldgaard, N. O., and C. G. Kurland. 1963. The distribution of soluble and
ribosomal RNA as a function of growth rate. J. Mol. Biol. 6:341–348.
12. Krogfelt, K. A., L. K. Poulsen, and S. Molin. 1993. Identification of coccoid
Escherichia coli BJ4 cells in the large intestine of streptomycin-treated mice.
Infect. Immun. 61:5029–5034.
13. Licht, T. R., K. A. Krogfelt, P. S. Cohen, L. K. Poulsen, J. Urbance, and S.
Molin. 1996. Role of lipopolysaccharide in colonization of the mouse intestine by Salmonella typhimurium studied by in situ hybridization. Infect. Immun. 64:3811–3817.
14. Licht, T. R., T. Tolker-Nielsen, K. Holmstrøm, K. A. Krogfelt, and S. Molin.
1999. Inhibition of Escherichia coli precursor-16S processing by mouse intestinal contents. Environ. Microbiol. 1:23–32.
15. McCormick, B. A., D. C. Laux, and P. S. Cohen. 1990. Neither motility nor
chemotaxis plays a role in the ability of Escherichia coli F-18 to colonize the
streptomycin-treated mouse large intestine. Infect. Immun. 58:2957–2961.
16. Møller, S., C. S. Kristensen, L. K. Poulsen, J. M. Carstensen, and S. Molin.
1995. Bacterial growth on surfaces: automated image analysis for quantification of growth rate-related parameters. Appl. Environ. Microbiol. 61:741–
748.
17. Poulsen, L. K., G. Ballard, and D. A. Stahl. 1993. Use of rRNA fluorescence
in situ hybridization for measuring the activity of single cells in young and
established biofilms. Appl. Environ. Microbiol. 59:1354–1360.
18. Poulsen, L. K., F. Lan, C. S. Kristensen, P. Hobolth, S. Molin, and K. A.
Krogfelt. 1994. Spatial distribution of Escherichia coli in the mouse large
intestine inferred from rRNA in situ hybridization. Infect. Immun. 62:5191–
5194.
19. Poulsen, L. K., T. R. Licht, C. Rang, K. A. Krogfelt, and S. Molin. 1995.
Physiological state of Escherichia coli BJ4 growing in the large intestines of
streptomycin-treated mice. J. Bacteriol. 177:5840–5845.
20. Salminen, S., E. Isolauri, and T. Onnela. 1995. Gut flora in normal and
disordered states. Chemotherapy (Basel) 41(Suppl. 1):5–15.
21. Schaechter, M., O. Maaloe, and N. O. Kjeldgard. 1958. Dependency on
medium and temperature of cell size and chemical composition during balanced growth of Salmonella typhimurium. J. Gen. Microbiol. 19:592–606.
22. Sweeney, N. J., P. Klemm, B. A. McCormick, E. Moller-Nielsen, M. Utley,
M. A. Schembri, D. C. Laux, and P. S. Cohen. 1996. The Escherichia coli
K-12 gntP gene allows E. coli F-18 to occupy a distinct nutritional niche in the
streptomycin-treated mouse large intestine. Infect. Immun. 64:3497–3503.
23. Sweeney, N. J., D. C. Laux, and P. S. Cohen. 1996. Escherichia coli F-18 and
E. coli K-12 eda mutants do not colonize the streptomycin-treated mouse
large intestine. Infect. Immun. 64:3504–3511.
24. Van der Waaij, D., J. M. Berghuis-de-Vries, and J. E. C. Lekkerkerk-van der
Wees. 1971. Colonization resistance of the digestive tract in conventional and
antibiotic treated mice. J. Hyg. Camb. 69:405–411.
25. Wadolkowski, E. A., D. C. Laux, and P. S. Cohen. 1988. Colonization of the
streptomycin-treated mouse large intestine by a human fecal Escherichia coli
strain: role of growth in mucus. Infect. Immun. 56:1030–1035.

Downloaded from http://cvi.asm.org/ on September 11, 2018 by guest

the estimated growth rates of BJ4 in the two models decreased
after conventionalization but were essentially identical to each
other at all times (Fig. 1), the more rapid loss of BJ4 in the
conventionalized germfree mice was independent of growth rate.
The data presented here show that E. coli grows in the
mouse gut at rates that are quite similar whether the animal is
monoassociated (germfree) or streptomycin treated (clearing
the major groups of gram-negative bacteria); i.e., in both models doubling times of about 75 min were observed (Fig. 2). The
data also show that in both the streptomycin-treated mouse
model and the monoassociated mouse model, the estimated
doubling times of E. coli BJ4 increased to between 116 and 130
min by nine days after conventionalization (Fig. 1). In streptomycin-treated mice, E. coli grows well in the intestinal mucus
layer, which covers the epithelial cells, but not in the luminal
contents in vivo and in vitro (14, 25). Moreover, nonmotile and
nonchemotactic E. coli mutants, when parents and mutants are
fed simultaneously to streptomycin-treated mice, colonize just
as well as their parents (15). Since the intestinal population
stays constant, it seems likely that E. coli must grow in the
mucus layer at a rate similar to that with which it is sloughed
into the luminal contents. If it is assumed that there is no
specific adhesion to any permanent surfaces in the intestine
(18), the rate of release of the mucus should determine the
growth rate of the bacteria. If so, the present experiments
suggest that conventionalization leads to a decrease in the rate
of mucus sloughing. Alternatively, it is possible that E. coli can
grow slower than the rate of mucus sloughing and still maintain
a stable population if a large proportion of bacteria is continuously pulled back into the mucus layer as water is resorbed to
form fecal pellets. In any event, the decrease in the bacterial
growth rate is in fact quite small, and the actual biological
impact of such a decrease remains unclear.
The different densities of E. coli in the different mouse
models are most likely caused by differences in nutrient availabilities. The spectrum of potential nutrients for one species
depends strictly on the competition from the other species
present. Finally, growth may be limited to specific parts of the
intestinal system in some but not all of the different animal
models; for example, it has been found that in germfree mice
E. coli grows very well in the intestinal contents, whereas, as
stated above, in streptomycin-treated (and most likely also
conventional) mice, growth in the contents is severely inhibited
(7, 14).
In conclusion, several factors appear to be important in
defining the growth conditions for bacteria in an ecosystem like
the mouse large intestine, factors such as nutrient availability,
flow rates, adhesion to permanent sites, presence of inhibitors,
competition from coresidents, etc. The in situ methods useful
for characterization of subpopulations of bacteria in complex
environments are important tools in building up a better understanding of the significance of these parameters.

